SWA
SUPN icon

Sutton Wealth Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Sutton Wealth Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-712
Closed -$25.4K – 1474
2022
Q4 		$25.4K Hold
712
– – 0.01% 600
2022
Q3 		$24.1K Hold
712
– – 0.01% 605
2022
Q2 		$20.6K Sell
712
-167
-19% -$4.78K 0.01% 666
2022
Q1 		$28.4K Buy
879
+20
+2% +$613 0.01% 597
2021
Q4 		$25K Buy
859
+155
+22% +$4.7K 0.01% 645
2021
Q3 		$18.8K Hold
704
– – 0.01% 709
2021
Q2 		$21.7K Hold
704
– – 0.01% 677
2021
Q1 		$18.4K Hold
704
– – 0.01% 696
2020
Q4 		$17.7K Hold
704
– – 0.01% 653
2020
Q3 		$14.7K Hold
704
– – 0.01% 631
2020
Q2 		$16.7K Hold
704
– – 0.01% 589
2020
Q1 		$12.7K Sell
704
-35
-5% -$736 0.01% 594
2019
Q4 		$17.5K Buy
739
+35
+5% +$850 0.01% 653
2019
Q3 		$19.3K Hold
704
– – 0.01% 589
2019
Q2 		$23.3K Hold
704
– – 0.01% 521
2019
Q1 		$24.7K Sell
704
-82
-10% -$3.05K 0.01% 508
2018
Q4 		$26.1K Buy
786
+82
+12% +$3.53K 0.02% 438
2018
Q3 		$35.4K Hold
704
– – 0.02% 384
2018
Q2 		$42.1K Hold
704
– – 0.03% 332
2018
Q1 		$32.2K Hold
704
– – 0.02% 395
2017
Q4 		$28.1K Hold
704
– – 0.02% 437
2017
Q3 		$28.2K Hold
704
– – 0.02% 420
2017
Q2 		$30.3K Hold
704
– – 0.02% 389
2017
Q1 		$22K Hold
704
– – 0.02% 484
2016
Q4 		$17.8K Hold
704
– – 0.02% 533
2016
Q3 		$17.4K Hold
704
– – 0.02% 501
2016
Q2 		$14.3K Hold
704
– – 0.01% 533
2016
Q1 		$10.7K Buy
+704
New +$9.19K 0.01% 595

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sutton Wealth Advisors's SUPN Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q1 2023, closing a stake of 712 shares — an estimated $25.4K sold.

Sutton Wealth Advisors first reported a position in SUPN in Q1 2016 and held it in 28 quarters. The position peaked at $42.1K in Q2 2018. 258 funds tracked by Wall St. Rank hold SUPN as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Supernus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 712 Supernus Pharmaceuticals shares in Q1 2023, an estimated $25.4K.
  • Sutton Wealth Advisors first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 28 quarters.
  • Sutton Wealth Advisors's Supernus Pharmaceuticals position peaked at $42.1K in Q2 2018.
  • 258 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.